Cytek Biosciences, Inc. (CTKB) vs Geron Corporation (GERN)
A side-by-side comparison of Cytek Biosciences, Inc. and Geron Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CTKB
Cytek Biosciences, Inc.
$5.77HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
GERN
Geron Corporation
$1.20HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — CTKB vs GERN
growth of $100 · dividends reinvested · last 5yCTKB -67.5% (-20.1%/yr)GERN -6.2% (-1.3%/yr)GERN compounded faster over this window
CTKB GERN
CTKB vs GERN: by the numbers
- •GERN is the larger company ($770M vs $745M market cap).
- •Both run net losses; GERN's is the smaller (-34.17% vs -38.98% net margin).
- •GERN grew revenue faster over the past five years (247.85% vs 13.37% CAGR).
Metrics side by side
Valuation
| Metric | CTKB | GERN |
|---|---|---|
| P/S ratio | 3.60 | 3.76 |
| P/B ratio | 2.31 | 3.52 |
Profitability
| Metric | CTKB | GERN |
|---|---|---|
| Gross margin | 53.23% | 97.42% |
| Operating margin | -21.60% | -29.28% |
| Net margin | -38.98% | -34.17% |
| ROE | -25.03% | -31.97% |
| ROIC | -12.00% | -8.34% |
Growth (annualized)
| Metric | CTKB | GERN |
|---|---|---|
| Revenue CAGR (5Y) | 13.37% | 247.85% |
| Total return CAGR (5Y) | -23.16% | -1.87% |
Frequently asked
- Which has grown faster, CTKB or GERN?
- Over the past five years, GERN grew revenue faster — CTKB at a 13.37% CAGR versus GERN at 247.85%.
- How have CTKB and GERN total returns compared?
- Over the past 5 years, CTKB delivered -23.16% and GERN delivered -1.87% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Cytek Biosciences ROEGeron ROECytek Biosciences operating marginGeron operating marginCytek Biosciences revenue growthGeron revenue growthCytek Biosciences free cash flowGeron free cash flow
Cytek Biosciences & Geron appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.